Page last updated: 2024-10-28

gyki 52466 and Bipolar Disorder

gyki 52466 has been researched along with Bipolar Disorder in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.

Research Excerpts

ExcerptRelevanceReference
" We found that chronic administration of the antimanic agents lithium and valproate (VPA) reduced synaptic AMPA receptor GluR1/2 in hippocampal neurons in vitro and in vivo."1.35The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. ( Blumenthal, R; Chen, G; Creson, TK; Du, J; Falke, C; Gray, NA; Machado-Vieira, R; Manji, HK; Ren, M; Wang, Y; Wei, Y; Wu, LJ; Yuan, P; Zhuo, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, J1
Creson, TK1
Wu, LJ1
Ren, M1
Gray, NA1
Falke, C1
Wei, Y1
Wang, Y1
Blumenthal, R1
Machado-Vieira, R1
Yuan, P1
Chen, G1
Zhuo, M1
Manji, HK1

Other Studies

1 other study available for gyki 52466 and Bipolar Disorder

ArticleYear
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Jan-02, Volume: 28, Issue:1

    Topics: Animals; Antimanic Agents; Behavior, Animal; Benzodiazepines; Bipolar Disorder; Cells, Cultured; Dis

2008